FAKTOR-OPTIONSSCHEIN - VIRBAC Stock

Certificat

DE000MG2XR64

Real-time Bid/Ask 09:47:00 2024-06-03 EDT
9.64 EUR / 9.78 EUR +1.57% Intraday chart for FAKTOR-OPTIONSSCHEIN - VIRBAC
1 month-11.56%
Date Price Change
24-06-03 9.54 -0.21%
24-05-31 9.56 -2.85%
24-05-30 9.84 -1.20%
24-05-29 9.96 +7.21%
24-05-28 9.29 +0.54%

Delayed Quote Börse Stuttgart

Last update June 03, 2024 at 04:42 am

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying VIRBAC
Issuer Morgan Stanley
WKN MG2XR6
ISINDE000MG2XR64
Date issued 2024-04-24
Strike 447.5
Maturity Unlimited
Parity 9.69 : 1
Emission price 10
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 11.35
Lowest since issue 8.5
Spread 0.14
Spread %1.42%

Company Profile

Virbac specializes in the research, production and marketing of veterinary medicines. The activity is organized around 2 product families: - pet medications: pest control drugs, vaccines, antibiotics, anesthetics, anti-inflammatory drugs, mouth/dental care products, ophthalmologic and dermatological products intended for dogs, cats, horses, birds, rodents, etc. The group also offers foods and electronic identification chips; - livestock medications: pest control drugs and antibiotics intended for cattle, sheep, pigs, poultry, etc. Net sales are distributed geographically as follows: France (15.4%), Europe (26.2%), Latin America (17.1%), Asia (16.4%), North America (13.2%), Pacific (9.3%), Africa and Middle East (2.4%).
Sector
-
More about the company

Ratings for Virbac

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Virbac

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
8
Last Close Price
358 EUR
Average target price
373.3 EUR
Spread / Average Target
+4.28%
Consensus